The World Health Organization (WHO) announced the formation of an international committee aimed at establishing uniform guidelines for editing human DNA in ways that can be passed down to future generations.
From battling disease in banana crops to overcoming avian flu, scientists are seeking wider acceptance for gene editing technology use in agriculture.
Researchers at The Pirbright Institute have published their procedures on video for creating a vaccine that protects against Marek’s disease and infectious bursal disease (IBD) using a CRISPR/Cas 9 gene editing system.
A method for making a version of a gene more likely to be inherited than normal, generating what is called a gene drive, might be used to control insect populations. It has now been reported to work in mammals, too.
Scientists have created an 'on' switch for CRISPR-Cas9 that allows it to be turned on in select cells only, specifically those that have a particular protein-cutting enzyme, or protease.
Researchers created a machine-learning model—inDelphi—that predicts how human and mouse cells will respond to CRISPR-induced breaks in DNA, discovering that cells often repair broken genes in ways that are precise and predictable.
The participants had all flocked to MIT for a three-day summit of biohackers from around the world, an event with the aim of democratizing science, taking technology that’s often hidden in keycard-access labs and bringing it to the people.
Researchers discovered a Cas9 enzyme that can target almost half of the locations on the genome, significantly widening its potential use.
A crucial part of the arsenal for shaping the future of gene editing is hiding in plain sight: the patent system. In the past, patents have played an important part in regulating new technologies and research.
Last week, a team used CRISPR-Cas9 to correct a single mistaken DNA letter in over a dozen human embryos, and succeeded in 16 out of 18 tries, a massive improvement over previous attempts.